IP Library Granted Patent US 11,951,186
Granted Patent B2
US 11,951,186 · App. 17/078,843 · Granted Apr 9, 2024

Indicator compounds, devices comprising indicator compounds, and methods of making and using the same

Inventors: Venkatramanan Krishnamani (Irvine, CA); Sergei Petrovich Balashov (Irvine, CA); Kevin Hughes Pauley (Lake Forest, CA); Ruiqi Long (Irvine, CA); Hung The Vo (Fountain Valley, CA)
Assignee: Willow Laboratories, Inc.
A61K49/0056A61B5/1455A61B5/1459A61B5/14735A61B5/1477A61K49/0045C07K14/245C07K14/43595A61B5/14532C07K2319/20C07K2319/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,951,186
App. No.
17/078,843
Granted
Apr 9, 2024
Kind
B2
Abstract

Some embodiments disclosed herein pertain to indicator compounds used to detect the presence of and/or an amount of an analyte. In some embodiments, the indicator compounds are fusion proteins. In some embodiments, when the analyte binds to the indicator compound, the indicator compound undergoes a conformational change. In some embodiments, the conformational change results in a luminescent signal that allows quantification of the amount of analyte present.

Claims (32)

1. A device for detecting the presence of an analyte in a subject, the device comprising:

a light transmissive material configured to receive an excitation wavelength of light from a light source;

a waveguide comprising a cladding layer that surrounds a core material, the waveguide being configured to receive the excitation wavelength of light via a proximal end of the waveguide and to transmit the excitation wavelength of light along the waveguide to a distal end of the waveguide, the distal end of the waveguide extending from the device, the distal end configured to penetrate the skin of the subject and reside in the dermis of the subject;

a flange coupled to the waveguide and configured to allow the distal end to penetrate to the dermis of the patient;

an adhesive layer contacting the flange, the adhesive layer configured to secure the device to the skin of the patient; and

an indicator compound comprising a fusion protein, the indicator compound being disposed within the waveguide and being configured to receive the excitation wavelength;

wherein the fusion protein comprises:

a luminescent protein domain; and

an analyte binding protein domain;

wherein, when the analyte binds to the analyte binding protein domain, the indicator compound undergoes a conformational change from a first conformation to a second conformation;

wherein, when in the second conformation, the indicator compound is configured to receive the excitation wavelength and to emit a luminescent signal;

wherein the luminescent signal is received by the waveguide and transmitted to the light transmissive material;

wherein the light transmissive material is configured to deliver the luminescent signal to a luminescence detector.

2. The device of claim 1 , wherein the waveguide further comprises a protective polymer layer over the cladding layer.

3. The device of claim 1 , wherein the indicator compound is distributed in the core of the waveguide, at the interface of the core and the cladding layer of the waveguide, in the cladding layer of the waveguide, at the surface of the cladding layer of the waveguide, or combinations of any of the foregoing.

4. The device of claim 1 , wherein the luminescent protein is a split luminescent protein.

5. The device of claim 1 , wherein the indicator compound shares 80% to 100% identity, homology, or similarity to one or more of SEQ ID NOs: 3-13 or 16-20.

6. The device of claim 1 , wherein the analyte binding protein domain is a domain of a periplasmic protein.

7. The device of claim 1 , wherein the analyte binding domain shares 80% to 100% identity, homology, or similarity to one of SEQ ID NOs: 2, 15, 122-221, or 824-1746.

8. The device of claim 1 , wherein the luminescent protein domain is a domain of a fluorescent protein.

9. The device of claim 1 , wherein the luminescent protein domain shares 80% to 100% identity, homology, or similarity to one or more of SEQ ID NOs: 1, 14, 34-121, or 222-823.

10. The device of claim 1 , wherein the waveguide is a biocompatible step-index fiber optical waveguide.

11. The device of claim 1 , wherein the waveguide comprises a fiber having a first refractive index and wherein the cladding layer has a second refractive index, wherein the first and second refractive indices are different.

12. The device of claim 1 , wherein the waveguide comprises one or more of a polyethylene glycol (PEG), an alginate hydrogel, a polyacrylamide hydrogel, an alginate-polyacrylamide hydrogel, a silk, a citrate-based polymeric elastomer, or a combination thereof.

13. The device of claim 1 , wherein the light transmissive material comprises a notch configured to receive the flange and waveguide.

14. A method for detecting an analyte in a patient comprising:

selecting a patient in need of analyte monitoring;

inserting into or attaching the device of claim 1 to the patient;

applying the excitation wavelength of light to the indicator compound.

15. The method of claim 14 , further comprising collecting the luminescent signal from the device.

16. The method of claim 14 , further comprising comparing the luminescent signal to a reference signal indicative of an indicator compound without an analyte bound.

17. The method of claim 14 , further comprising quantifying an amount of luminescent signal as a concentration of analyte.

Assignments (4)
PROPRIETARY INFORMATION AND INVENTOR’S AGREEMENT Recorded Aug 27, 2024
From: PAULEY, KEVIN
To: MASIMO LABORATORIES
Reel/Frame 068788/0390 →
CHANGE OF NAME Recorded Mar 6, 2024
From: CERCACOR LABORATORIES, INC.
To: WILLOW LABORATORIES, INC.
Reel/Frame 066745/0328 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2023
From: KRISHNAMANI, VENKATRAMANAN; BALASHOV, SERGEI PETROVICH; PAULEY, KEVIN HUGHES; LONG, RUIGI; VO, HUNG THE
To: CERCACOR LABORATORIES, INC.
Reel/Frame 065964/0594 →
CHANGE OF NAME Recorded Dec 27, 2023
From: MASIMO LABORATORIES, INC.
To: CERCACOR LABORATORIES, INC.
Reel/Frame 066663/0753 →
Continuity (3)
Provisional Application 63019126 · May 1, 2020
Provisional Application 62926323 · Oct 25, 2019
Related Publication 20210121582A1 · Apr 29, 2021
Cited By (124)
US 1,060,680 US 1,063,893 US 1,066,244 US 1,066,672 US 1,068,656 US 1,071,195 US 1,078,689 US 1,079,020 US 1,083,653 US 1,085,102 US 1,092,244 US 1,095,288 US 1,095,483 US 1,106,466 US 1,119,639 US 1,124,917 US 1,127,209 US 1,132,251 US 1,140,023 US 12,186,079 US 12,193,813 US 12,193,849 US 12,198,790 US 12,201,420 US 12,201,702 US 12,205,208 US 12,207,419 US 12,207,901 US 12,211,617 US 12,214,274 US 12,220,205 US 12,220,207 US 12,220,257 US 12,226,206 US 12,230,391 US 12,230,393 US 12,230,396 US 12,232,888 US 12,232,905 US 12,235,941 US 12,235,947 US 12,236,767 US 12,237,081 US 12,238,489 US 12,257,022 US 12,257,081 US 12,257,183 US 12,263,018 US 12,272,445 US 12,283,374 US 12,295,708 US 12,302,426 US 12,310,695 US 12,318,175 US 12,318,176 US 12,318,196 US 12,318,229 US 12,318,580 US 12,322,185 US 12,329,548 US 12,336,796 US 12,343,108 US 12,343,142 US 12,347,202 US 12,357,181 US 12,357,203 US 12,357,237 US 12,362,596 US 12,364,403 US 12,367,973 US 12,374,843 US 12,383,194 US 12,390,114 US 12,390,140 US 12,394,285 US 12,396,667 US 12,402,816 US 12,402,843 US 12,408,869 US 12,419,588 US 12,433,524 US 12,440,128 US 12,440,171 US 12,465,270 US 12,465,286 US 12,478,272 US 12,478,293 US 12,484,844 US 12,495,967 US 12,495,968 US 12,495,998 US 12,495,999 US 12,507,952 US 12,514,503 US 12,521,021 US 12,521,039 US 12,521,506 US 12,533,068 US 12,533,089 US 12,539,046 US 12,541,293 US 12,558,033 US 12,573,286 US 12,575,797 US 12,582,313 US 12,587,806 US 12,593,980 US 12,609,013 US 12,611,117 US 12,616,623 US 12,642,491 US 12,648,718 US 12,661,039 US 12,661,488 US 12,667,307 US 12,677,331 US 12,689,232 US 12,691,223 US 12,694,892 US 12,702,202 US 12,702,333 US 12,702,755 US 12,708,328 US 12,714,369